يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Prow, D."', وقت الاستعلام: 1.26s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  10. 10
    دورية أكاديمية

    المؤلفون: Fizazi K; Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. fizazi@igr.fr, Prow DM, Do KA, Wang X, Finn L, Kim J, Daliani D, Papandreou CN, Tu SM, Millikan RE, Pagliaro LC, Logothetis CJ, Amato RJ

    المصدر: British journal of cancer [Br J Cancer] 2002 May 20; Vol. 86 (10), pp. 1555-60.

    نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article

    بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Print ISSN: 0007-0920 (Print) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

    مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Germinoma/*drug therapy , Seminoma/*drug therapy , Testicular Neoplasms/*drug therapy, Adolescent ; Adult ; Anemia, Refractory, with Excess of Blasts/chemically induced ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor/blood ; Bleomycin/administration & dosage ; Bleomycin/adverse effects ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Dactinomycin/administration & dosage ; Dactinomycin/adverse effects ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Etoposide/administration & dosage ; Etoposide/adverse effects ; Gastrointestinal Diseases/chemically induced ; Germinoma/mortality ; Germinoma/pathology ; Germinoma/secondary ; Hematologic Diseases/chemically induced ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/secondary ; Male ; Methotrexate/administration & dosage ; Methotrexate/adverse effects ; Middle Aged ; Peripheral Nervous System Diseases/chemically induced ; Prognosis ; Prospective Studies ; Remission Induction ; Seminoma/mortality ; Seminoma/pathology ; Seminoma/secondary ; Survival Analysis ; Survival Rate ; Testicular Neoplasms/mortality ; Testicular Neoplasms/pathology ; Treatment Outcome ; Vincristine/administration & dosage ; Vincristine/adverse effects

    SCR Protocol: BOP-CISCA-POMB-ACE regimen